Skip to main content

Royalty Pharma plc 10-Q for FY2024 Q3

Royalty Pharma plc (RPRX)

10-Q 2024-11-06 For: 2024-09-30
View Original
Added on April 07, 2026

About this 10-Q

Royalty Pharma plc filed this 10-Q on November 6, 2024, covering the quarter ended September 30, 2024 (FY2024 Q3).

Headline figures

Quarter ended September 30, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$564.69M
up 5.3% from $536.31M a year earlier
Net income
$543.99M
up 654.3% from net income of $72.11M a year earlier
Diluted EPS
$1.21
up 656.3% from $0.16 a year earlier